^Roger, P.; Auclair, J.; Drain, P. (1999). “Addition of Benfluorex to Biguanide Improves Glycemic Control in Obese Non-Insulin-Dependent Diabetes: A Double-Blind Study versus Placebo”. Journal of Diabetes and its Complications13 (2): 62–67. doi:10.1016/S1056-8727(98)00004-X. PMID10432168.
^Frachon, Irène, et al. (2010). “Benfluorex and unexplained valvular heart disease: a case-control study”. PLoS One5 (4): e10128. doi:10.1371/journal.pone.0010128. PMID20405030.
^Weill, Alain, et al. (2010). “Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus”. Pharmacoepidemiology and drug safety19 (12): 1256-1262. doi:10.1002/pds.2044. PMID20945504.
^Rothman, Richard B., et al. (2000). “Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications”. Circulation102 (23): 2836-2841. doi:10.1161/01.CIR.102.23.2836. PMID11104741.